OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter (OTC) products containing its SlimBiome technology for the Asian market.
The multinational is a major supplier of nutritional solutions to the food, beverage, nutraceutical and pharmaceutical industries within Asia, and increasingly across global markets.
OptiBiotix’s benefits of this deal are in developing weight management products containing SlimBiome technology in a range of foods and OTC products which, if successful, will be launched into the Asian market in the second half of 2017.
The company said it requires its identity and commercial details to remain confidential and no further details can be disclosed at this time.
OptiBiotix added that discussions are ongoing and it is hoped a further announcement can be made in due course.
Stephen O’Hara, CEO of OptiBiotix, commented: “We are pleased to announce the signing of this Agreement with a multinational which creates the opportunity to launch products containing OptiBiotix’s SlimBiome into the Asian market next year. The multinational is a leading supplier of food ingredients with many well-known and respected brands and a multibillion dollar turnover. With India (30m) and China (46m) ranked second and third in having the highest number of overweight people in the world we hope that OptiBiotix’s strong science base together with our partner’s local knowledge, reputation, and sales and distribution capability will bring the benefits of SlimBiome technology to a wider audience.”